The ABPI's President Haseeb Ahmad has written a comment piece on the launch of our 2020 Manifesto for Medicine.
The Conservatives have announced a commitment to further funding for dementia research, doubling existing funding levels.
The Conservative Party has said it will launch a £500 million fund to give patients quicker access to the most cutting-edge medicines for cancer and other diseases.
The UK is leading the rest of Europe for early-stage clinical research into new medicines and vaccines, with more than 600 commercial clinical trials taking place in the NHS.
“Pharmaceutical companies have done everything in their power to prepare for a ‘no deal’ Brexit. This includes increasing stocks of medicines, changing and adding new supply routes and duplicating manufacturing processes here and in Europe."
We have launched our General Election manifesto calling on all parties to ensure that their policies support UK science and research and help maintain the UK’s position as a global leader in medicines and vaccines development into the future.
The Smith-Reid review into science and research funding post-Brexit has been published with recommendations for how the UK Government can promote an exciting, well-resourced vision for international collaboration in research and innovation.
NHS England has today published a draft commercial framework setting out more operational detail on commercial arrangements with industry. There will now be an engagement process to make sure that the final framework is informed by a broad range of views.
NHS England has announced it has secured an agreement with Vertex to make available all three of their UK-licensed cystic fibrosis medicines.
The Prime Minister has demanded urgent action to tackle declining vaccination rates for MMR. This is the right approach, says Dr Sheuli Porkess of the ABPI.